Implantation of left atrial appendage (LAA) occluders is a minimally invasive procedure aimed at preventing thrombus formation in the left atrial appendage in patients with atrial fibrillation. The left atrial appendage is a small anatomical structure where blood clots frequently form in patients with cardiac rhythm disorders; these clots can lead to ischemic strokes. An occluder is a special device that seals the LAA, excluding it from the bloodstream and significantly reducing the risk of thromboembolic complications.
When is LAA occluder implantation performed?
The procedure is indicated for patients with a high risk of stroke who cannot take anticoagulant medications (blood thinners) due to contraindications or significant side effects.
Main indications:
- Atrial fibrillation. Permanent or paroxysmal forms associated with a high risk of thrombus formation.
- Contraindications to anticoagulants. A history of bleeding or a high risk of hemorrhagic complications.
- Ineffectiveness of drug therapy. Situations in which anticoagulant treatment does not adequately reduce thromboembolic risk.
- Stroke prevention. Reduction of embolic complications in patients with atrial fibrillation.
Advantages of the method
- Minimally invasive approach. The procedure is performed via vascular access without the need for open-heart surgery.
- Reduced stroke risk. Excluding the left atrial appendage from circulation markedly lowers the likelihood of thromboembolism.
- No need for lifelong anticoagulation. Patients can avoid long-term anticoagulant therapy and its associated risks.
- Rapid recovery. Most patients return to normal daily activities within a few days.
How is the procedure performed?
Pre-procedural assessment
The patient undergoes comprehensive evaluation, including:
- Transesophageal echocardiography to assess the size and shape of the left atrial appendage.
- CT or MRI for detailed visualization of cardiac anatomy.
- ECG and blood tests to evaluate overall health and coagulation status.
Implantation procedure
- Anesthesia. Performed under local anesthesia with sedation or under general anesthesia.
- Cardiac access. A catheter is introduced through a puncture in the femoral vein and guided to the heart. Transseptal puncture allows access to the left atrium.
- Occluder deployment. Under echocardiographic and fluoroscopic guidance, the device is delivered to the left atrial appendage and deployed to seal its entrance.
- Verification. After confirming correct positioning and secure fixation, the catheter is removed.
Procedure duration
The intervention usually takes 1–2 hours.
Post-procedural period
- In-hospital observation. The patient remains under medical supervision for 1–2 days to monitor for early complications.
- Short-term antithrombotic therapy. Anticoagulants or antiplatelet agents may be prescribed temporarily to prevent thrombus formation on the device.
- Physical activity. Limitation of strenuous activity is recommended during the first week.
- Device follow-up. Regular echocardiographic examinations are performed to confirm stable device position and exclude complications.
Clinical outcomes
- Stroke risk reduction. LAA occluder implantation effectively prevents thromboembolic events in the majority of patients.
- Improved quality of life. Avoidance of long-term anticoagulant therapy increases comfort and safety.
- Long-term durability. The occluder is designed for lifelong implantation without the need for replacement.
Implantation of left atrial appendage occluders in Belarus is an effective and safe method for stroke prevention in patients with atrial fibrillation, particularly for those who cannot tolerate anticoagulant therapy. Owing to its minimally invasive nature, short recovery period, and high clinical efficacy, this procedure significantly improves patient safety and quality of life. Regular medical follow-up and adherence to physician recommendations are essential to maintain optimal outcomes and minimize risks.
Q&A
Окклюдер устанавливается пожизненно и не требует замены.
Большинство пациентов возвращаются к обычной деятельности через несколько дней после процедуры.
